The NEPHSTROM trial team in Galway has developed a new trial visit workflow to meet the public health guidelines for COVID-19 protection for patients. They were able to successfully complete the end-of-study visit protocol for one of the NEPHSTROM patients and will complete further trial visits in a similar manner in July.
Prof Matthew Griffin, of NUI Galway and Galway University Hospitals, “To date, one end-of-study trial visit has been safely completed. This was only possible because of the expertise and ingenuity of Dr Veronica McInerney who developed the COVID-19 risk assessment and secured a safe location for us to run the protocol with minimal risk to all involved, and of Nathan Devaney and Sarah Cormican who spent the day along with Veronica working carefully with our patient and samples”.
Visit the NEPHSTROM website at www.nephstrom.eu
Follow NEPHSTROM on Twitter @NEPHSTROM.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634086. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.